Hepatitis B virus antisense oligonucleotide(Spring Bank Pharmaceuticals)

N/A

Report date: 2025/03/18 14:44:52
NME

Base Information

Drug NameHepatitis B virus antisense oligonucleotide(Spring Bank Pharmaceuticals)
Drug Alias NameSB-11527SB-527
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionHepatitis B virus replication inhibitorsHBsAg inhibitors
TargetsHepatitis B Surface Antigens
Therapy Area/IndicationsHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesSpring Bank Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesSpring Bank Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsHepatitis B
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A